Abiopharma

News list

Duarte Ira 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Jan 19, 2026 | Filing ID: 016423

Full text

News bot Jan. 29, 2026, 2:22 p.m.
🔍 Duarte Ira (Executive)

Company: HERON THERAPEUTICS, INC. /DE/ (HRTX)

Report Date: 2026-01-19
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,875
- Total shares sold: 3,875
Detailed Transactions and Holdings:
- Acquired 3,875 shares of Common Stock (Direct)
  Date: 2026-01-19 | Code: M | equity_swap_involved: false | shares_owned_after: 183,661.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,875 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-19 | Code: M | equity_swap_involved: false | shares_owned_after: 30,994.00 | transaction_form_type: 4 | Footnotes: F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).